Cargando…
Doppler myocardial performance index combined with plasma B-type natriuretic peptide levels as a marker of cardiac function in patients with decompensated cirrhosis
BACKGROUND: In chronic liver diseases, cirrhosis ranks as the 14th highest death cause worldwide, developing into decompensated cirrhosis. A potential and feasible technique in assessing cardiac function is urgent. This study explores if the Doppler myocardial performance (Tei) index combined with t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283142/ https://www.ncbi.nlm.nih.gov/pubmed/30508917 http://dx.doi.org/10.1097/MD.0000000000013302 |
_version_ | 1783379130796998656 |
---|---|
author | Wang, Li-Kun An, Xiao-Fei Wu, Xue-Liang Zhang, Su-Mei Yang, Rui-Min Han, Chao Yang, Jie-Lin Wang, Yi-Cheng |
author_facet | Wang, Li-Kun An, Xiao-Fei Wu, Xue-Liang Zhang, Su-Mei Yang, Rui-Min Han, Chao Yang, Jie-Lin Wang, Yi-Cheng |
author_sort | Wang, Li-Kun |
collection | PubMed |
description | BACKGROUND: In chronic liver diseases, cirrhosis ranks as the 14th highest death cause worldwide, developing into decompensated cirrhosis. A potential and feasible technique in assessing cardiac function is urgent. This study explores if the Doppler myocardial performance (Tei) index combined with the plasma B-type natriuretic peptide (BNP) levels can assess cardiac function in patients with decompensated cirrhosis. METHODS: A total of 140 individuals were selected in the study and were classified into 3 groups: control group (n = 40, healthy individuals), compensated cirrhosis group (n = 50), and decompensated cirrhosis group (n = 50). Plasma BNP levels, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), and albumin (ALB) were identified by an enzyme-linked immunosorbent assay (ELISA). The correlation of Tei index between left ventricle (LV) and right ventricle (RV) as well as plasma BNP levels with cardiac function was assessed using a Pearson test analysis. All patients were subjected to this experiment for 1 year to analyze the relationship between Tei index and plasma BNP levels in prognosis of decompensated cirrhosis patients. RESULTS: Patients with decompensated cirrhosis showed significantly elevated levels of ALT, AST, and TBIL level in contrary to a reduced ALB level. Cirrhosis patients also showed a significantly reduced ejection fraction (ET) index, but an increase in isovolumetric contraction time (ICT), isovolumetric relaxation time (IRT), Tei index, and plasma BNP levels in comparison to healthy individuals. ICT, IRT, Tei index, and plasma BNP levels were elevated in decompensated cirrhotic patients as opposed to compensated cirrhotic patients. These results indicate a positive correlation of both Tei index and plasma BNP levels with cirrhosis and its progression. Tei index and plasma BNP levels are positively associated with Child–Pugh classification and negatively correlated with both cardiac function and prognosis in patients suffering from decompensated cirrhosis. CONCLUSION: The study provided evidence supporting the correlation of Tei index and plasma BNP levels in decompensated cirrhotic patients with cardiac function, highlighting a potential value for evaluation. |
format | Online Article Text |
id | pubmed-6283142 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-62831422018-12-26 Doppler myocardial performance index combined with plasma B-type natriuretic peptide levels as a marker of cardiac function in patients with decompensated cirrhosis Wang, Li-Kun An, Xiao-Fei Wu, Xue-Liang Zhang, Su-Mei Yang, Rui-Min Han, Chao Yang, Jie-Lin Wang, Yi-Cheng Medicine (Baltimore) Research Article BACKGROUND: In chronic liver diseases, cirrhosis ranks as the 14th highest death cause worldwide, developing into decompensated cirrhosis. A potential and feasible technique in assessing cardiac function is urgent. This study explores if the Doppler myocardial performance (Tei) index combined with the plasma B-type natriuretic peptide (BNP) levels can assess cardiac function in patients with decompensated cirrhosis. METHODS: A total of 140 individuals were selected in the study and were classified into 3 groups: control group (n = 40, healthy individuals), compensated cirrhosis group (n = 50), and decompensated cirrhosis group (n = 50). Plasma BNP levels, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), and albumin (ALB) were identified by an enzyme-linked immunosorbent assay (ELISA). The correlation of Tei index between left ventricle (LV) and right ventricle (RV) as well as plasma BNP levels with cardiac function was assessed using a Pearson test analysis. All patients were subjected to this experiment for 1 year to analyze the relationship between Tei index and plasma BNP levels in prognosis of decompensated cirrhosis patients. RESULTS: Patients with decompensated cirrhosis showed significantly elevated levels of ALT, AST, and TBIL level in contrary to a reduced ALB level. Cirrhosis patients also showed a significantly reduced ejection fraction (ET) index, but an increase in isovolumetric contraction time (ICT), isovolumetric relaxation time (IRT), Tei index, and plasma BNP levels in comparison to healthy individuals. ICT, IRT, Tei index, and plasma BNP levels were elevated in decompensated cirrhotic patients as opposed to compensated cirrhotic patients. These results indicate a positive correlation of both Tei index and plasma BNP levels with cirrhosis and its progression. Tei index and plasma BNP levels are positively associated with Child–Pugh classification and negatively correlated with both cardiac function and prognosis in patients suffering from decompensated cirrhosis. CONCLUSION: The study provided evidence supporting the correlation of Tei index and plasma BNP levels in decompensated cirrhotic patients with cardiac function, highlighting a potential value for evaluation. Wolters Kluwer Health 2018-11-30 /pmc/articles/PMC6283142/ /pubmed/30508917 http://dx.doi.org/10.1097/MD.0000000000013302 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | Research Article Wang, Li-Kun An, Xiao-Fei Wu, Xue-Liang Zhang, Su-Mei Yang, Rui-Min Han, Chao Yang, Jie-Lin Wang, Yi-Cheng Doppler myocardial performance index combined with plasma B-type natriuretic peptide levels as a marker of cardiac function in patients with decompensated cirrhosis |
title | Doppler myocardial performance index combined with plasma B-type natriuretic peptide levels as a marker of cardiac function in patients with decompensated cirrhosis |
title_full | Doppler myocardial performance index combined with plasma B-type natriuretic peptide levels as a marker of cardiac function in patients with decompensated cirrhosis |
title_fullStr | Doppler myocardial performance index combined with plasma B-type natriuretic peptide levels as a marker of cardiac function in patients with decompensated cirrhosis |
title_full_unstemmed | Doppler myocardial performance index combined with plasma B-type natriuretic peptide levels as a marker of cardiac function in patients with decompensated cirrhosis |
title_short | Doppler myocardial performance index combined with plasma B-type natriuretic peptide levels as a marker of cardiac function in patients with decompensated cirrhosis |
title_sort | doppler myocardial performance index combined with plasma b-type natriuretic peptide levels as a marker of cardiac function in patients with decompensated cirrhosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283142/ https://www.ncbi.nlm.nih.gov/pubmed/30508917 http://dx.doi.org/10.1097/MD.0000000000013302 |
work_keys_str_mv | AT wanglikun dopplermyocardialperformanceindexcombinedwithplasmabtypenatriureticpeptidelevelsasamarkerofcardiacfunctioninpatientswithdecompensatedcirrhosis AT anxiaofei dopplermyocardialperformanceindexcombinedwithplasmabtypenatriureticpeptidelevelsasamarkerofcardiacfunctioninpatientswithdecompensatedcirrhosis AT wuxueliang dopplermyocardialperformanceindexcombinedwithplasmabtypenatriureticpeptidelevelsasamarkerofcardiacfunctioninpatientswithdecompensatedcirrhosis AT zhangsumei dopplermyocardialperformanceindexcombinedwithplasmabtypenatriureticpeptidelevelsasamarkerofcardiacfunctioninpatientswithdecompensatedcirrhosis AT yangruimin dopplermyocardialperformanceindexcombinedwithplasmabtypenatriureticpeptidelevelsasamarkerofcardiacfunctioninpatientswithdecompensatedcirrhosis AT hanchao dopplermyocardialperformanceindexcombinedwithplasmabtypenatriureticpeptidelevelsasamarkerofcardiacfunctioninpatientswithdecompensatedcirrhosis AT yangjielin dopplermyocardialperformanceindexcombinedwithplasmabtypenatriureticpeptidelevelsasamarkerofcardiacfunctioninpatientswithdecompensatedcirrhosis AT wangyicheng dopplermyocardialperformanceindexcombinedwithplasmabtypenatriureticpeptidelevelsasamarkerofcardiacfunctioninpatientswithdecompensatedcirrhosis |